Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study to Evaluate the Safety and Immunogenicity of the Vaccine Booster With the Trivalent UFRJvac COVID-19 Vaccine

NCT06303635 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.

NCT NCT06303635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06303635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study to Evaluate the Safety and Immunogenicity of the Vaccine Booster With the Trivalent UFRJvac COVID-19 Vaccine
Lead sponsor
Azidus Brasil
Phase
Observational
Overall status
Unknown status
Start date
June 24, 2024
Completion date
November 25, 2025
Enrollment
156 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy people